The strong biotechnology ecosystem in the United States is supporting the development of advanced antibody-drug conjugate therapies. Pharmaceutical companies and research institutions are investing in oncology innovation, clinical research, and targeted drug development.
Market Overview
The Antibody Drug Conjugates Market is projected to reach US$38,077.45 million by 2031 from US$8,105.65...
